virus
initi
encount
host
take
place
cell
nonlymphat
origin
outcom
primari
infect
determin
cours
diseas
cytokin
respons
infect
cell
play
vital
part
type
interferon
potent
antivir
activ
cytokin
produc
bodi
cell
respons
viru
infect
ifn
trigger
synthesi
antivir
activ
protein
also
activ
innat
immun
system
help
shape
adapt
immun
virusinduc
cytokin
chemokin
activ
adapt
immun
system
direct
migrat
leukocyt
virus
hand
evolv
variou
mechan
counteract
host
cytokin
respons
abil
induc
inhibit
cytokin
product
infect
cell
direct
consequ
balanc
host
defens
viru
propag
sar
coronaviru
sarscov
etiolog
agent
sever
acut
respiratori
syndrom
sar
lifethreaten
new
human
diseas
recent
emerg
china
characterist
sar
symptom
high
fever
myalgia
dri
cough
lymphopenia
around
case
patient
also
develop
atyp
form
pneumonia
mechan
underli
sarscovmedi
pathogenesi
remain
larg
unexplain
autopsi
deceas
patient
reveal
sever
damag
lung
lymphat
tissu
accompani
infiltr
monocyt
cell
may
indic
immunopathogenesi
involv
sever
outcom
diseas
provid
rational
sar
therapi
immunosuppress
corticosteroid
hand
evid
cell
damag
could
directli
caus
viru
sinc
sarscov
cytolyt
capabl
system
infect
human
host
addit
viru
particl
sign
necrosi
found
affect
tissu
high
viral
load
predict
advers
clinic
outcom
interestingli
howev
acut
lung
injuri
respiratori
failur
observ
sever
case
occur
viral
load
declin
favour
hypothesi
immunemedi
lung
damag
virusinduc
cytokin
play
signific
role
host
defens
also
immunopathogenesi
investig
cytokin
profil
sar
patient
shown
proinflammatori
cytokin
chemokin
strongli
upregul
cell
cultur
studi
contrast
reveal
clear
pictur
sarscovinduc
cytokin
case
upregul
wherea
case
either
cytokin
induc
moder
upregul
detect
thu
still
unclear
whether
cytokin
storm
sar
patient
directli
caus
viru
ie
produc
sarscovinfect
cell
whether
secondari
effect
ie
result
strong
activ
immun
system
one
notabl
except
studi
investig
cellular
cytokin
respons
sarscov
either
base
immun
cell
hepatoma
cell
inocul
unphysiolog
high
amount
viru
thu
overal
pictur
cytokin
respons
nonimmun
cell
probabl
prime
target
sarscov
may
still
incomplet
learn
human
cell
line
would
need
one
hand
support
complet
viral
replic
cycl
hand
also
abl
produc
cytokin
potenti
antivir
howev
cell
line
permiss
sarscov
lost
abil
synthes
ifn
potent
antivir
cytokin
studi
identifi
ifncompet
human
embryon
kidney
hek
cell
clone
support
growth
sarscov
use
cell
well
establish
human
colon
carcinoma
cell
line
investig
sarscovinduc
product
repres
cytokin
chemokin
antivir
gene
studi
reveal
sarscov
capabl
suppress
antivir
cytokin
respons
infect
cell
larg
extent
interestingli
howev
induct
chemokin
escap
suppress
sarscov
cell
hek
thu
sarscov
effici
block
innat
host
cell
defens
earli
step
infect
buy
time
colon
host
possibl
except
cytokin
detect
sar
patient
may
therefor
produc
infiltr
immun
cell
resid
tissu
cell
data
may
help
explain
rapid
rise
viru
titer
initi
stage
diseas
caus
suppress
antivir
cytokin
well
progress
infiltr
immun
cell
infect
lung
could
due
product
chemokin
infect
tissu
cell
vero
cell
standard
growth
sarscov
lack
type
ifn
gene
therefor
suitabl
cytokin
analys
search
appropri
vitro
system
test
sever
ifncompet
human
cell
line
sarscov
growth
identifi
lowpassag
clone
hek
cell
fulli
permiss
fig
show
titer
hek
cell
vero
cell
compar
rather
high
alreadi
h
postinfect
cell
contrast
produc
approxim
less
viru
h
postinfect
less
h
postinfect
fig
thu
consid
cell
low
passag
hek
cell
use
system
studi
influenc
sarscov
immun
systemindepend
induct
cytokin
properli
assess
cytokin
profil
sarscov
infect
compar
wellcharacter
cytokin
induc
bunyamwera
delnss
viru
bdnss
sendai
viru
sev
newcastl
diseas
viru
ndv
addit
deem
necessari
monitor
cytokin
synthesi
h
h
postinfect
sinc
previous
found
strike
differ
earli
late
host
cell
respons
sarscov
first
set
test
cytokin
compris
classic
antivir
cytokin
novel
interferon
test
induct
cell
cultur
infect
plaqueform
unit
pfu
virus
per
cell
analyz
cytokin
mrna
rtpcr
shown
fig
clear
signal
ifn
detect
infect
control
virus
bdnss
sev
ndv
sarscov
contrast
weak
signal
detect
hek
cell
none
either
cell
line
prepar
contain
similar
amount
input
rna
sinc
control
mrna
present
equal
amount
fig
lower
panel
interest
see
whether
viru
infect
would
lead
upregul
antivir
ifnstimul
gene
isg
specif
sensit
marker
use
gene
induc
ifn
viru
infect
mxa
gene
exclus
activ
ifn
evid
fig
signific
isg
induct
occur
sarscov
wherea
control
virus
activ
isg
express
note
sev
block
hek
cell
synthesi
see
fig
upper
right
panel
mxa
fig
lower
right
panel
probabl
abil
inhibit
ifninduc
signal
curious
happen
cell
fig
lower
right
panel
suggest
cell
typespecif
differ
cytokin
signal
taken
togeth
data
demonstr
contrast
virus
test
sarscov
suppress
activ
antivir
ifn
ifninduc
effector
gene
larg
extent
rant
potent
chemoattract
activ
cell
nk
cell
infect
cell
signific
amount
mrna
synthes
fig
upper
panel
strong
upregul
occur
independ
viru
suggest
gener
respons
viru
infect
although
mrna
level
induc
h
pi
sarscov
slightli
lower
virus
data
good
agreement
previou
studi
induct
rant
contrast
restrict
cytokineinduc
virus
wherea
infect
sarscov
effect
background
level
fig
lower
panel
test
hek
cell
similar
way
much
surpris
mrna
detect
earli
infect
sarscov
fig
upper
left
panel
weakli
express
longer
infect
fig
upper
right
panel
rant
mrna
detect
sarscov
fig
lower
panel
three
cytokineinduc
virus
activ
rant
express
hek
cell
expect
fig
upper
lower
panel
thu
sarscov
induc
gene
express
cell
hek
cell
suggest
cytokin
respons
depend
host
cell
type
rant
express
contrast
never
induc
sarscov
although
cell
respond
normal
virus
proinflammatori
cytokin
chemokin
strongli
upregul
sar
patient
cell
cultur
studi
clear
pictur
emerg
investig
product
hek
cell
infect
sarscov
compar
rna
virus
shown
fig
induc
weakli
sarscov
independ
cell
line
use
fig
upper
panel
contrast
clearli
induc
sarscov
cell
hek
cell
fig
lower
panel
control
virus
invari
induc
demonstr
cell
line
capabl
produc
cytokin
thu
sarscov
strongli
induc
celltyp
depend
manner
may
suggest
detect
sar
patient
directli
synthes
infect
resid
cell
wherea
like
secondari
respons
mediat
infiltr
immun
cell
taken
togeth
data
demonstr
sarscov
gener
weak
induc
cytokin
antivir
gene
nonlymphat
cell
chemokin
like
howev
directli
upregul
sarscov
celltypedepend
manner
activ
immunerelev
cytokin
host
cell
gene
sarscov
cell
patient
subject
sever
previou
investig
howev
cell
cultur
studi
either
base
immun
cell
repres
major
infect
cell
hepatoma
cell
need
infect
pfu
per
cell
ie
unphysiolog
high
amount
viru
moreov
cell
known
defici
antivir
cytokin
respons
thu
entir
clear
whether
patient
cytokin
respons
caus
virusinfect
cell
whether
mediat
activ
immun
system
furthermor
systemat
investig
cytokin
induct
sarscov
compar
virus
use
three
control
virus
two
differ
cell
line
elucid
compar
induct
cytokin
sarscov
result
demonstr
sarscov
induc
signific
amount
ifn
antivir
gene
rant
agreement
find
sarscovinfect
macrophag
dendrit
cell
lack
ifn
induct
howev
activ
sarscov
suggest
chemokin
reliabl
marker
acutestag
sar
produc
respons
activ
immun
system
suggest
may
also
directli
secret
infect
tissu
cell
upregul
either
andor
observ
sever
studi
use
sarscovinfect
cell
macrophag
peripher
blood
mononuclear
cell
dendrit
cell
use
hek
cell
contrast
found
sarscov
abl
downregul
also
product
similarli
recent
studi
show
peripher
blood
monocyt
sar
patient
produc
cytokin
thu
chemokin
induct
sarscov
appear
highli
cell
typespecif
except
sarscov
capabl
suppress
product
wide
rang
cytokin
agreement
previou
find
sarscov
inhibit
crucial
cytokin
transcript
factor
provid
possibl
mechan
high
potenti
pathogen
suppress
host
respons
note
sarscov
highli
sensit
antivir
action
ifn
vivo
vitro
thu
explain
viru
need
suppress
ifn
induct
advanc
initi
phase
sar
viru
grow
exponenti
spread
differ
organ
includ
lung
data
may
explain
rapid
effici
dissemin
sarscov
slow
express
ifn
antivir
gene
infect
tissu
cell
viru
buy
time
initi
critic
phase
infect
order
grow
unhind
host
time
howev
virusinduc
chemokin
attract
immun
cell
possibl
mixtur
highlevel
viru
replic
follow
invas
activ
immun
cell
result
strong
inflammatori
respons
lead
cytokin
storm
sever
potenti
fatal
respiratori
distress
hallmark
fullblown
sar
simian
cell
human
cell
human
embryon
kidney
hek
cell
maintain
grown
describ
lowpassag
hek
cell
clone
purchas
microbix
biosystem
toronto
canada
experi
perform
hek
cell
passag
isol
sarscov
kindli
provid
stephan
becker
univers
marburg
germani
bunyamwera
delnss
viru
sendai
viru
newcastl
diseas
viru
use
control
viru
plaqu
assay
perform
describ
previous
briefli
vero
cell
monolay
infect
dilut
supernat
infect
cell
overlaid
soft
agar
allow
form
plaqu
h
agar
overlay
remov
cell
stain
solut
crystal
violet
formaldehyd
methanol
ethanol
cell
infect
indic
time
total
rna
extract
treat
dnase
revers
transcript
rt
rna
incub
u
superscript
ii
revers
transcriptas
invitrogen
ng
random
hexanucleotid
buffer
invitrogen
suppli
mm
four
deoxynucleotid
triphosph
u
rnasin
mm
dithiothreitol
result
cdna
amplifi
cycl
pcr
cycl
consist
sec
min
use
primer
pair
specif
rant
primer
pair
min
follow
min
primer
sequenc
avail
author
upon
request
bdnss
bunyamwera
delnss
viru
hek
human
embryon
kidney
ifn
interferon
il
interleukin
isg
interferonstimul
gene
ndv
newcastl
diseas
viru
rant
regul
activ
normal
cell
express
secret
sarscov
sar
coronaviru
sev
sendai
viru
author
declar
compet
interest
ms
carri
viru
growth
studi
rtpcr
analys
particip
design
studi
given
final
approv
version
publish
fw
carri
viru
infect
particip
design
studi
respons
draft
final
manuscript
author
read
approv
final
manuscript
